International Journal of Cancer Management

Published by: Kowsar

Methylenetetrahydrofolate Reductase (MTHFR) C677T and A1298C Variants, Folate Intake, and Susceptibility to Breast Cancer

Zohreh Rahimi 1 , 2 , * , Marayam Bozorgi 1 , 2 and Ebrahim Shakiba 2 , **
Authors Information
1 Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
2 Department of Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
Corresponding Authors:
Article information
  • International Journal of Cancer Management: November 2017, 10 (11); e9528
  • Published Online: November 30, 2017
  • Article Type: Review Article
  • Received: October 29, 2016
  • Revised: December 13, 2016
  • Accepted: November 6, 2017
  • DOI: 10.5812/ijcm.9528

To Cite: Rahimi Z, Bozorgi M, Shakiba E. Methylenetetrahydrofolate Reductase (MTHFR) C677T and A1298C Variants, Folate Intake, and Susceptibility to Breast Cancer, Int J Cancer Manag. 2017 ;10(11):e9528. doi: 10.5812/ijcm.9528.

Abstract
© 2017, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Acknowledgements
Footnotes
References
  • 1. Rahimi Z, Kasraei R, Najafi F, Tanhapoor M, Abdi H, Rahimi Z, et al. Cancer notification at a referral hospital of Kermanshah, Western Iran (2006-2009). Asian Pac J Cancer Prev. 2015;16(1):133-7. [PubMed: 25640340].
  • 2. Rahimi Z, Yari K, Rahimi Z. Matrix metalloproteinase-9 -1562T allele and its combination with MMP-2 -735 C allele are risk factors for breast cancer. Asian Pac J Cancer Prev. 2015;16(3):1175-9. [PubMed: 25735351].
  • 3. Sanjari Moghaddam A, Nazarzadeh M, Noroozi R, Darvish H, Mosavi Jarrahi A. XRCC1 and OGG1 Gene Polymorphisms and Breast Cancer: A Systematic Review of Literature. Iran J Cancer Prev. 2016;9(1):3467. doi: 10.17795/ijcp-3467. [PubMed: 27366307].
  • 4. Mahdi KM, Nassiri MR, Nasiri K. Hereditary genes and SNPs associated with breast cancer. Asian Pac J Cancer Prev. 2013;14(6):3403-9. [PubMed: 23886119].
  • 5. Yari K, Rahimi Z, Moradi MT, Rahimi Z. The MMP-2 -735 C allele is a risk factor for susceptibility to breast cancer. Asian Pac J Cancer Prev. 2014;15(15):6199-203. [PubMed: 25124598].
  • 6. Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 2004;6(5):213-8. doi: 10.1186/bcr921. [PubMed: 15318928].
  • 7. Abdulrahman GJ, Rahman GA. Epidemiology of breast cancer in europe and Africa. J Cancer Epidemiol. 2012;2012:915610. doi: 10.1155/2012/915610. [PubMed: 22693503].
  • 8. Yari K, Rahimi Z, Payandeh M, Rahimi Z. MMP-7 A-181G Polymorphism in Breast Cancer Patients from Western Iran. Breast Care (Basel). 2015;10(6):398-402. doi: 10.1159/000442231. [PubMed: 26989359].
  • 9. Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, et al. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res. 2005;65(4):1606-14. doi: 10.1158/0008-5472.CAN-04-2630. [PubMed: 15735051].
  • 10. Rahimi Z, Azhar MR, Rahimi Z, Yari K. Interaction of thymidylate synthase polymorphism with MTHFR variants modify the risk of childhood acute lymphoblastic leukemia. Biharian Biologist. 2012;6:87-9.
  • 11. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem. 1999;10(2):66-88. [PubMed: 15539274].
  • 12. Galbiatti AL, Ruiz MT, Maniglia JV, Raposo LS, Pavarino-Bertelli EC, Goloni-Bertollo EM. Head and neck cancer: genetic polymorphisms and folate metabolism. Braz J Otorhinolaryngol. 2012;78(1):132-9. [PubMed: 22392251].
  • 13. Naushad SM, Pavani A, Rupasree Y, Divyya S, Deepti S, Digumarti RR, et al. Association of aberrations in one-carbon metabolism with molecular phenotype and grade of breast cancer. Mol Carcinog. 2012;51 Suppl 1:32-41. doi: 10.1002/mc.21830. [PubMed: 22086855].
  • 14. Zhang CX, Ho SC, Chen YM, Lin FY, Fu JH, Cheng SZ. Dietary folate, vitamin B6, vitamin B12 and methionine intake and the risk of breast cancer by oestrogen and progesterone receptor status. Br J Nutr. 2011;106(6):936-43. doi: 10.1017/S0007114511001140. [PubMed: 21736840].
  • 15. Rahimi Z, Hasanvand A, Felehgari V. Interaction of MTHFR 1298C with ACE D allele augments the risk of diabetic nephropathy in Western Iran. DNA Cell Biol. 2012;31(4):553-9. doi: 10.1089/dna.2011.1364. [PubMed: 21942443].
  • 16. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet. 1994;7(2):195-200. doi: 10.1038/ng0694-195. [PubMed: 7920641].
  • 17. Yari K, Payandeh M, Rahimi Z. Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran. Tumour Biol. 2016;37(6):8145-52. doi: 10.1007/s13277-015-4731-1. [PubMed: 26715274].
  • 18. Rahimi M, Hasanvand A, Rahimi Z, Vaisi-Raygani A, Mozafari H, Rezaei M, et al. Synergistic effects of the MTHFR C677T and A1298C polymorphisms on the increased risk of micro- and macro-albuminuria and progression of diabetic nephropathy among Iranians with type 2 diabetes mellitus. Clin Biochem. 2010;43(16-17):1333-9. doi: 10.1016/j.clinbiochem.2010.08.019. [PubMed: 20800057].
  • 19. Lopez-Cortes A, Jaramillo-Koupermann G, Munoz MJ, Cabrera A, Echeverria C, Rosales F, et al. Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population. Am J Med Sci. 2013;346(6):447-54. doi: 10.1097/MAJ.0b013e3182882578. [PubMed: 23459165].
  • 20. Xu X, Gammon MD, Zhang H, Wetmur JG, Rao M, Teitelbaum SL, et al. Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis. 2007;28(7):1504-9. doi: 10.1093/carcin/bgm061. [PubMed: 17372271].
  • 21. Platek ME, Shields PG, Marian C, McCann SE, Bonner MR, Nie J, et al. Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2453-9. doi: 10.1158/1055-9965.EPI-09-0159. [PubMed: 19706843].
  • 22. Campbell IG, Baxter SW, Eccles DM, Choong DY. Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res. 2002;4(6):14. [PubMed: 12473175].
  • 23. Ericson U, Sonestedt E, Ivarsson MI, Gullberg B, Carlson J, Olsson H, et al. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmo Diet and Cancer cohort. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1101-10. doi: 10.1158/1055-9965.EPI-08-0401. [PubMed: 19336565].
  • 24. Papandreou CN, Doxani C, Zdoukopoulos N, Vlachostergios PJ, Hatzidaki E, Bakalos G, et al. Evidence of association between methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a candidate-gene association study in a South-eastern European population. DNA Cell Biol. 2012;31(2):193-8. doi: 10.1089/dna.2011.1292. [PubMed: 21875371].
  • 25. Ramos-Silva A, Figuera LE, Soto-Quintana OM, Puebla-Perez AM, Ramirez-Patino R, Gutierrez-Hurtado I, et al. Association of the C677T polymorphism in the methylenetetrahydrofolate reductase gene with breast cancer in a Mexican population. Genet Mol Res. 2015;14(2):4015-26. doi: 10.4238/2015.April.27.16. [PubMed: 25966173].
  • 26. de Cassia Carvalho Barbosa R, da Costa DM, Cordeiro DE, Vieira AP, Rabenhorst SH. Interaction of MTHFR C677T and A1298C, and MTR A2756G gene polymorphisms in breast cancer risk in a population in Northeast Brazil. Anticancer Res. 2012;32(11):4805-11. [PubMed: 23155246].
  • 27. Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, et al. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis. 2008;29(2):356-62. doi: 10.1093/carcin/bgm295. [PubMed: 18174236].
  • 28. Kotsopoulos J, Zhang WW, Zhang S, McCready D, Trudeau M, Zhang P, et al. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat. 2008;112(3):585-93. doi: 10.1007/s10549-008-9895-6. [PubMed: 18204969].
  • 29. Henriquez-Hernandez LA, Murias-Rosales A, Hernandez Gonzalez A, Cabrera De Leon A, Diaz-Chico BN, Mori De Santiago M, et al. Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: a case-control study. Oncol Rep. 2009;22(6):1425-33. [PubMed: 19885596].
  • 30. Justenhoven C, Hamann U, Pierl CB, Rabstein S, Pesch B, Harth V, et al. One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol Biomarkers Prev. 2005;14(12):3015-8. doi: 10.1158/1055-9965.EPI-05-0592. [PubMed: 16365030].
  • 31. Vainer AS, Boiarskikh UA, Voronina EN, Selezneva IA, Sinkina TV, Lazarev AF, et al. [Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR, C1420T SHMT1 and G1958A MTHFD) are not associated with the risk of breast cancer in West Siberian Region of Russia]. Mol Biol (Mosk). 2010;44(5):816-23. [PubMed: 21090237].
  • 32. Weiwei Z, Liping C, Dequan L. Association between dietary intake of folate, vitamin B6, B12 & MTHFR, MTR Genotype and breast cancer risk. Pak J Med Sci. 2014;30(1):106-10. doi: 10.12669/pjms.301.4189. [PubMed: 24639841].
  • 33. Jiang-Hua Q, De-Chuang J, Zhen-Duo L, Shu-de C, Zhenzhen L. Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast cancer risk and interaction with folate, vitamin B6, and vitamin B 12 intakes. Tumour Biol. 2014;35(12):11895-901. doi: 10.1007/s13277-014-2456-1. [PubMed: 25217320].
  • 34. He JM, Pu YD, Wu YJ, Qin R, Zhang QJ, Sun YS, et al. Association between dietary intake of folate and MTHFR and MTR genotype with risk of breast cancer. Genet Mol Res. 2014;13(4):8925-31. doi: 10.4238/2014.October.31.7. [PubMed: 25366783].
  • 35. Hosseini M, Houshmand M, Ebrahimi A. MTHFR polymorphisms and breast cancer risk. Arch Med Sci. 2011;7(1):134-7. doi: 10.5114/aoms.2011.20618. [PubMed: 22291746].
  • 36. Awwad N, Yousef AM, Abuhaliema A, Abdalla I, Yousef M. Relationship between Genetic Polymorphisms in MTHFR (C677T, A1298C and their Haplotypes) and the Incidence Of Breast Cancer among Jordanian Females--Case-Control Study. Asian Pac J Cancer Prev. 2015;16(12):5007-11. [PubMed: 26163632].
  • 37. Ergul E, Sazci A, Utkan Z, Canturk NZ. Polymorphisms in the MTHFR gene are associated with breast cancer. Tumour Biol. 2003;24(6):286-90. [PubMed: 15004488].
  • 38. Semenza JC, Delfino RJ, Ziogas A, Anton-Culver H. Breast cancer risk and methylenetetrahydrofolate reductase polymorphism. Breast Cancer Res Treat. 2003;77(3):217-23. [PubMed: 12602921].
  • 39. Ozen F, Erdis E, Sik E, Silan F, Uludag A, Ozdemir O. Germ-line MTHFR C677T, FV H1299R and PAI-1 5G/4G variations in breast carcinoma. Asian Pac J Cancer Prev. 2013;14(5):2903-8. [PubMed: 23803051].
  • 40. Akilzhanova A, Nurkina Z, Momynaliev K, Ramanculov E, Zhumadilov Z, Rakhypbekov T, et al. Genetic profile and determinants of homocysteine levels in Kazakhstan patients with breast cancer. Anticancer Res. 2013;33(9):4049-59. [PubMed: 24023349].
  • 41. Mohammad NS, Yedluri R, Addepalli P, Gottumukkala SR, Digumarti RR, Kutala VK. Aberrations in one-carbon metabolism induce oxidative DNA damage in sporadic breast cancer. Mol Cell Biochem. 2011;349(1-2):159-67. doi: 10.1007/s11010-010-0670-8. [PubMed: 21113649].
  • 42. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Hebert JR, et al. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev. 2004;13(2):190-6. [PubMed: 14973091].
  • 43. Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Khuhaprema T, Yoshida T. Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women. Breast Cancer Res Treat. 2010;123(3):885-93. doi: 10.1007/s10549-010-0804-4. [PubMed: 20180013].
  • 44. Cheng CW, Yu JC, Huang CS, Shieh JC, Fu YP, Wang HW, et al. Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res Treat. 2008;111(1):145-55. doi: 10.1007/s10549-007-9754-x. [PubMed: 17896178].
  • 45. Akram M, Malik FA, Kayani MA. Mutational analysis of the MTHFR gene in breast cancer patients of Pakistani population. Asian Pac J Cancer Prev. 2012;13(4):1599-603. [PubMed: 22799374].
  • 46. Lajin B, Alhaj Sakur A, Ghabreau L, Alachkar A. Association of polymorphisms in one-carbon metabolizing genes with breast cancer risk in Syrian women. Tumour Biol. 2012;33(4):1133-9. doi: 10.1007/s13277-012-0354-y. [PubMed: 22373582].
  • 47. Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, et al. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Breast Cancer Res Treat. 2010;123(2):499-506. doi: 10.1007/s10549-010-0773-7. [PubMed: 20135343].
  • 48. Zhong S, Chen Z, Yu X, Li W, Tang J, Zhao J. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in breast cancer. Mol Biol Rep. 2014;41(9):5775-85. doi: 10.1007/s11033-014-3450-9. [PubMed: 24973876].
  • 49. Rai V. The methylenetetrahydrofolate reductase C677T polymorphism and breast cancer risk in Asian populations. Asian Pac J Cancer Prev. 2014;15(14):5853-60. [PubMed: 25081713].
  • 50. Kumar P, Yadav U, Rai V. Methylenetetrahydrofolate reductase gene C677T polymorphism and breast cancer risk: Evidence for genetic susceptibility. Meta Gene. 2015;6:72-84. doi: 10.1016/j.mgene.2015.08.008. [PubMed: 26629412].
  • 51. Xie SZ, Liu ZZ, Yu JH, Liu L, Wang W, Xie DL, et al. Association between the MTHFR C677T polymorphism and risk of cancer: evidence from 446 case-control studies. Tumour Biol. 2015;36(11):8953-72. doi: 10.1007/s13277-015-3648-z. [PubMed: 26081619].
  • 52. Deroo LA, Bolick SC, Xu Z, Umbach DM, Shore D, Weinberg CR, et al. Global DNA methylation and one-carbon metabolism gene polymorphisms and the risk of breast cancer in the Sister Study. Carcinogenesis. 2014;35(2):333-8. doi: 10.1093/carcin/bgt342. [PubMed: 24130171].
  • 53. Ma E, Iwasaki M, Junko I, Hamada GS, Nishimoto IN, Carvalho SM, et al. Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMC Cancer. 2009;9:122. doi: 10.1186/1471-2407-9-122. [PubMed: 19389261].
  • 54. Azhar MR, Rahimi Z, Vaisi-Raygani A, Akramipour R, Madani H, Rahimi Z, et al. Lack of association between MTHFR C677T and A1298C polymorphisms and risk of childhood acute lymphoblastic leukemia in the Kurdish population from Western Iran. Genet Test Mol Biomarkers. 2012;16(3):198-202. doi: 10.1089/gtmb.2011.0041. [PubMed: 22017305].
  • 55. Stevens VL, McCullough ML, Pavluck AL, Talbot JT, Feigelson HS, Thun MJ, et al. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1140-7. doi: 10.1158/1055-9965.EPI-06-1037. [PubMed: 17548676].
  • 56. Chou YC, Wu MH, Yu JC, Lee MS, Yang T, Shih HL, et al. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan. Carcinogenesis. 2006;27(11):2295-300. doi: 10.1093/carcin/bgl108. [PubMed: 16777985].
  • 57. Xu X, Gammon MD, Wetmur JG, Bradshaw PT, Teitelbaum SL, Neugut AI, et al. B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2109-16. doi: 10.1158/1055-9965.EPI-07-2900. [PubMed: 18708404].
  • 58. Alshatwi AA. Breast cancer risk, dietary intake, and methylenetetrahydrofolate reductase (MTHFR)single nucleotide polymorphisms. Food Chem Toxicol. 2010;48(7):1881-5. doi: 10.1016/j.fct.2010.04.028. [PubMed: 20417243].
  • 59. Ericson UC, Ivarsson MI, Sonestedt E, Gullberg B, Carlson J, Olsson H, et al. Increased breast cancer risk at high plasma folate concentrations among women with the MTHFR 677T allele. Am J Clin Nutr. 2009;90(5):1380-9. doi: 10.3945/ajcn.2009.28064. [PubMed: 19759169].
  • 60. Kakkoura MG, Demetriou CA, Loizidou MA, Loucaides G, Neophytou I, Marcou Y, et al. Single-nucleotide polymorphisms in one-carbon metabolism genes, Mediterranean diet and breast cancer risk: a case-control study in the Greek-Cypriot female population. Genes Nutr. 2015;10(2):453. doi: 10.1007/s12263-015-0453-7. [PubMed: 25604861].

Altmetric:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Comments